OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EMRO50

Emrock Corporation Ltd

Construction & EngineeringVerified

Emrock Corporation Ltd has a basic and diluted share count of 15,820,000 shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for Emrock Corporation Ltd, as the valuation snapshot does not provide data on return on invested capital (ROIC), operating margins, or other key performance indicators. This lack of data makes it difficult to assess the company's financial health relative to industry benchmarks. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it challenging to evaluate the diversification of its revenue streams or the risks associated with geographic concentration. Growth trajectory data is also not available, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. This absence of forward-looking guidance limits the ability to assess the company's growth potential. The risk assessment indicates a low level of dilution risk, but the liquidity risk remains unassessed. The absence of balance-sheet inputs and no going-concern language in the source documents suggests that further due diligence is required to understand the company's financial stability. Recent events, including filings and transcripts, are not disclosed in the available data, which limits the ability to assess the company's recent performance and strategic direction.

30-day price · EMRO+36.10 (+14.4%)
Low$228.90High$305.95Close$286.70As of12 May, 00:00 UTC
Profile
CompanyEmrock Corporation Ltd
TickerEMRO.BO
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryConstruction & Engineering
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Emrock Corporation Ltd has a basic and diluted share count of 15,820,000 shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for Emrock Corporation Ltd, as the valuation snapshot does not provide data on return on invested capital (ROIC), operating margins, or other key performance indicators. This lack of data makes it difficult to assess the company's financial health relative to industry benchmarks. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it challenging to evaluate the diversification of its revenue streams or the risks associated with geographic concentration. Growth trajectory data is also not available, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. This absence of forward-looking guidance limits the ability to assess the company's growth potential. The risk assessment indicates a low level of dilution risk, but the liquidity risk remains unassessed. The absence of balance-sheet inputs and no going-concern language in the source documents suggests that further due diligence is required to understand the company's financial stability. Recent events, including filings and transcripts, are not disclosed in the available data, which limits the ability to assess the company's recent performance and strategic direction.
Key takeaways
  • Emrock Corporation Ltd has no immediate dilution pressure based on the current share count.
  • The company's liquidity risk remains unassessed due to the lack of balance-sheet data.
  • Profitability and return metrics are not available, making it difficult to evaluate financial performance.
  • Revenue concentration and geographic exposure are not disclosed, limiting the understanding of diversification risks.
  • Growth trajectory and forward-looking guidance are not available, which hinders the assessment of future potential.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$1.0M-$54.0k
FY-3-$892.0k$515.0k
FY-2-$809.0k$595.0k
FY-1-$733.0k-$1.0M
FY0$5.0M$570.9k$1.7M$1.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$76.1M$71.5M$135.0k
FY-3$72.4M$72.0M-$1.0k
FY-2$73.3M$72.6M
FY-1$71.8M$71.6M
FY0$83.1M$73.3M-$510.00
PeriodOCFCapExFCFSBC
FY-4-$1.2M$0.00
FY-3-$4.4M$0.00
FY-2-$933.0k$0.00
FY-1
FY0-$9.6M-$58.0k$1.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$0.00-$344.0k$64.0k
FQ-5$0.00-$405.0k$15.0k
FQ-4$0.00-$264.0k$117.0k
FQ-3$5.0M$1.6M$1.5M
FQ-2
FQ-1$3.4M
FQ0$5.2M$4.8M$3.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5$72.0M$71.7M$121.0k
FQ-4
FQ-3$83.1M$73.3M$359.5k
FQ-2
FQ-1$148.9M$141.5M$793.0k
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5-$927.0k$0.00
FQ-4
FQ-3-$9.6M-$58.0k
FQ-2
FQ-1-$60.5M-$71.0k$3.4M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Industrial & Commercial Services · cohort 1120 companies
MetricEMROActivity
Op margin4.7% medp25 0.8% · p75 10.1%
Net margin3.3% medp25 0.3% · p75 7.0%
Gross margin14.9% medp25 8.8% · p75 27.2%
CapEx / revenue-1.4% medp25 -4.1% · p75 -0.4%
Debt / equity40.5% medp25 8.2% · p75 95.8%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:27 UTC#83e5de14
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 20:57 UTCJob: 51ac4725